X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (438) 438
ugt1a1 (408) 408
glucuronosyltransferase - genetics (360) 360
index medicus (300) 300
female (228) 228
male (219) 219
genotype (167) 167
bilirubin (166) 166
irinotecan (162) 162
adult (161) 161
gilberts-syndrome (159) 159
pharmacology & pharmacy (158) 158
middle aged (149) 149
ugt1a1 gene (145) 145
polymorphism, genetic (144) 144
hyperbilirubinemia (130) 130
polymorphism (119) 119
aged (111) 111
oncology (111) 111
genetic aspects (110) 110
camptothecin - analogs & derivatives (105) 105
pharmacogenetics (91) 91
glucuronosyltransferase - metabolism (86) 86
mutation (83) 83
glucuronidation (82) 82
bilirubin - blood (81) 81
genetic polymorphisms (77) 77
promoter (77) 77
metabolism (75) 75
cancer (74) 74
expression (68) 68
polymorphisms (68) 68
risk factors (68) 68
research (67) 67
genetics & heredity (66) 66
toxicity (66) 66
colorectal cancer (65) 65
enzymes (60) 60
gilbert disease - genetics (60) 60
chemotherapy (59) 59
alleles (57) 57
gene (56) 56
pharmacokinetics (56) 56
camptothecin - adverse effects (55) 55
biochemistry & molecular biology (54) 54
udp-glucuronosyltransferase (54) 54
gilbert syndrome (53) 53
promoter regions, genetic (53) 53
animals (52) 52
gene frequency (52) 52
genes (51) 51
genetic predisposition to disease (51) 51
pediatrics (51) 51
crigler-najjar syndrome (49) 49
analysis (48) 48
association (48) 48
gilbert's syndrome (48) 48
active metabolite (46) 46
infant, newborn (46) 46
metastatic colorectal-cancer (46) 46
neonatal hyperbilirubinemia (46) 46
asian continental ancestry group - genetics (45) 45
polymorphism, single nucleotide (44) 44
camptothecin - administration & dosage (43) 43
colorectal neoplasms - drug therapy (43) 43
young adult (43) 43
risk (42) 42
care and treatment (41) 41
neutropenia (41) 41
unconjugated hyperbilirubinemia (40) 40
case-control studies (39) 39
colorectal neoplasms - genetics (39) 39
adolescent (38) 38
aged, 80 and over (38) 38
bilirubin udp-glucuronosyltransferase (38) 38
liver (38) 38
physiological aspects (38) 38
sn-38 (38) 38
gastroenterology & hepatology (36) 36
population (36) 36
bilirubin - metabolism (35) 35
genetic research (35) 35
serum bilirubin (35) 35
crigler-najjar syndrome - genetics (34) 34
digestive system (34) 34
ugt1a1 promoter (34) 34
genetics (33) 33
health aspects (33) 33
jaundice (33) 33
udp-glucuronosyltransferase gene (33) 33
udp-glucuronosyltransferase-1 (33) 33
camptothecin - therapeutic use (32) 32
hyperbilirubinemia - genetics (32) 32
medicine, research & experimental (32) 32
antineoplastic agents, phytogenic - adverse effects (31) 31
breast-cancer (31) 31
hematology (31) 31
pharmacogenomics (31) 31
treatment outcome (31) 31
antineoplastic combined chemotherapy protocols - therapeutic use (30) 30
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (644) 644
Japanese (7) 7
German (5) 5
Korean (5) 5
Spanish (5) 5
French (2) 2
Polish (2) 2
Russian (2) 2
Hungarian (1) 1
Italian (1) 1
Lithuanian (1) 1
Persian (1) 1
Portuguese (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Indian Journal of Pediatrics, ISSN 0019-5456, 7/2016, Volume 83, Issue 7, pp. 723 - 725
Journal Article
Journal Article
Clinical Chemistry and Laboratory Medicine, ISSN 1434-6621, 03/2018, Volume 56, Issue 4, pp. 554 - 558
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2011, Volume 6, Issue 10, p. e26620
Journal Article
Journal Article
BMC pediatrics, ISSN 1471-2431, 05/2019, Volume 19, Issue 1, pp. 173 - 3
Crigler-Najjar syndrome (CNs) presents as unconjugated hyperbilirubinemia, as a result of UGT1A1 deficiency, and can be categorized in a severe (type I) and... 
Care and treatment | Genetic aspects | Hyperbilirubinemia | Research | Gene mutations | Pediatric research | Enzymes | Parents & parenting | Liver | Hemoglobin | Mutation | Metabolism | Binding sites | Crigler-Najjar syndrome | UGT1A1 | HNF-1α | Genetic analysis
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 09/2017, Volume 17, Issue 1, pp. 622 - 8
Background: Dolutegravir (DTG) is metabolized mainly by uridine diphosphate (UDP)-glucuronosyltransferase 1A1 (UGT1A1), and partly by cytochrome P450 3A... 
UGT1A1 gene polymorphism | Plasma trough concentration | Neuropsychiatric adverse events | Dolutegravir | POPULATION | INFECTIOUS DISEASES | ONCE-DAILY DOLUTEGRAVIR | RALTEGRAVIR | EFFICACY | HIV-1-INFECTED PATIENTS | INTOLERANCE | DISCONTINUATION | NAIVE PATIENTS | PHARMACOKINETICS | Neuropsychiatric adverseevents | COMBINATION ANTIRETROVIRAL THERAPY | HIV-1 - pathogenicity | Dizziness - genetics | Gene Frequency | HIV Infections - genetics | Humans | Middle Aged | Asian Continental Ancestry Group - genetics | Dizziness - chemically induced | Male | Polymorphism, Genetic | Sleep Initiation and Maintenance Disorders - chemically induced | Glucuronosyltransferase - genetics | Anxiety - genetics | HIV Integrase Inhibitors - adverse effects | Heterocyclic Compounds, 3-Ring - blood | Heterocyclic Compounds, 3-Ring - adverse effects | Alleles | Sleep Initiation and Maintenance Disorders - genetics | Adult | Female | HIV Infections - drug therapy | HIV Integrase Inhibitors - blood | Anxiety - chemically induced | Infection | Complications and side effects | Analysis | Genetic aspects | HIV (Viruses) | Health aspects | Genetic polymorphisms | Risk factors | Cytochrome | Headache | Statistical analysis | Cytochrome P450 | Heterozygotes | Clinical trials | Viruses | Multivariate analysis | Gene polymorphism | Patients | Homozygotes | Sleep disorders | Acquired immune deficiency syndrome--AIDS | Insomnia | Human immunodeficiency virus--HIV | Uridine | Anxiety | Drug therapy | Polymorphism | Glucuronosyltransferase
Journal Article